| Evaluation of a preoperative personalized risk communication tool: a prospective before-and-after study H Emily, D Yachnin, L Boland, K Wilson, A McKinnon, H Kira, H Terry, ... Canadian Journal of Anesthesia 67 (12), 1749-1760, 2020 | 16 | 2020 |
| Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials M Foster, DA Fergusson, T Hawrysh, J Presseau, N Kekre, S Schwartz, ... Research Involvement and Engagement 6, 1-10, 2020 | 15 | 2020 |
| CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies N Kekre, KA Hay, JR Webb, R Mallick, JS Nielsen, J Quizi, SD Brown, ... Frontiers in immunology 13, 1074740, 2022 | 14 | 2022 |
| Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early … G Castillo, MM Lalu, S Asad, M Foster, N Kekre, DA Fergusson, ... BMJ open 11 (3), e043929, 2021 | 13 | 2021 |
| Hematologists’ barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study G Castillo, M Lalu, S Asad, M Foster, N Kekre, D Fergusson, T Hawrysh, ... Trials 22, 1-13, 2021 | 9 | 2021 |
| Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the … M Wilson, K Thavorn, T Hawrysh, ID Graham, H Atkins, N Kekre, D Coyle, ... BMJ open 11 (8), e046707, 2021 | 5 | 2021 |
| Engaging Patients and Caregivers in an Early Health Economic Evaluation: Discerning Treatment Value Based on Lived Experience M Wilson, K Thavorn, T Hawrysh, ID Graham, H Atkins, N Kekre, D Coyle, ... PharmacoEconomics 40 (11), 1119-1130, 2022 | 3 | 2022 |
| Building a Platform for Meaningful Patient Partnership to Accelerate" Bench-to-Bedside" Translation of Promising New Therapies. G Fox, DA Fergusson, M Foster, T Hawrysh, S Dupont, DJ Walling, M Irwin, ... Healthcare Quarterly (Toronto, Ont.) 24 (SP), 74-79, 2022 | 3 | 2022 |
| Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review K Thavorn, ER Thompson, S Kumar, A Heiskanen, A Agarwal, H Atkins, ... Value in Health, 2024 | 1 | 2024 |
| PCN136 ECONOMIC VIABILITY OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR ADULTS WITH ADVANCED LEUKEMIA: EVIDENCE FROM AN EARLY ECONOMIC MODELLING K Thavorn, S Van Katwyk, N Kekre, H Atkins, T Hawrysh, M Lalu, ... Value in Health 22, S461-S462, 2019 | 1 | 2019 |
| Patient and Public Perceptions in Canada about Decentralized and Hybrid Clinical Trials:“It’s about time we bring trials to people” DP Richards, J Queenan, L Aasen-Johnston, H Douglas, T Hawrysh, ... Therapeutic Innovation & Regulatory Science 58 (5), 965-977, 2024 | | 2024 |
| POSC363 Engaging Patients and Caregivers in Health Economic Evaluations: Generating Stakeholder Input to Inform the Conduct of an Early Economic Evaluation of Chimeric Antigen … M Wilson, K Thavorn, T Hawrysh, ID Graham, H Atkins, N Kekre, D Coyle, ... Value in Health 25 (1), S243, 2022 | | 2022 |
| Protocol: Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder … M Wilson, K Thavorn, T Hawrysh, ID Graham, H Atkins, N Kekre, D Coyle, ... BMJ Open 11 (8), 2021 | | 2021 |
| Partnering with Patients to Get Better Outcomes with Chimeric Antigen Receptor T-cell Therapy: Towards Meaningful Patient Engagement in Early Phase Trials M Foster, D Fergusson, T Hawrysh, J Presseau, N Kekre, S Schwartz, ... Ottawa Hospital Research Institute, 2020 | | 2020 |
| Plain English Summary (250 words) M Foster, MHA Dean Fergusson, T Hawrysh, J Presseau, N Kekre, ... | | |
